The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program

This study examines the effectiveness of diagnosis restrictions as a drug utilization control in California's Medi-Cal (Medicaid) program. The numbers of Valium prescriptions dispensed, the numbers of Medi-Cal beneficiaries using Valium and the expenditures represented by those prescriptions we...

Descripción completa

Detalles Bibliográficos
Autores principales: Boisseree, Victor R., Keith, John C., Little, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 1984
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191364/
https://www.ncbi.nlm.nih.gov/pubmed/10310598
_version_ 1782338647583883264
author Boisseree, Victor R.
Keith, John C.
Little, Daniel L.
author_facet Boisseree, Victor R.
Keith, John C.
Little, Daniel L.
author_sort Boisseree, Victor R.
collection PubMed
description This study examines the effectiveness of diagnosis restrictions as a drug utilization control in California's Medi-Cal (Medicaid) program. The numbers of Valium prescriptions dispensed, the numbers of Medi-Cal beneficiaries using Valium and the expenditures represented by those prescriptions were measured during application of a diagnosis restriction for a 33-month base period, followed by removal of the diagnosis restriction for a 14-month period.
format Online
Article
Text
id pubmed-4191364
institution National Center for Biotechnology Information
language English
publishDate 1984
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41913642014-11-04 The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program Boisseree, Victor R. Keith, John C. Little, Daniel L. Health Care Financ Rev Special Report This study examines the effectiveness of diagnosis restrictions as a drug utilization control in California's Medi-Cal (Medicaid) program. The numbers of Valium prescriptions dispensed, the numbers of Medi-Cal beneficiaries using Valium and the expenditures represented by those prescriptions were measured during application of a diagnosis restriction for a 33-month base period, followed by removal of the diagnosis restriction for a 14-month period. CENTERS for MEDICARE & MEDICAID SERVICES 1984 /pmc/articles/PMC4191364/ /pubmed/10310598 Text en
spellingShingle Special Report
Boisseree, Victor R.
Keith, John C.
Little, Daniel L.
The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program
title The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program
title_full The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program
title_fullStr The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program
title_full_unstemmed The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program
title_short The Valium Project: Diagnostic restrictions as a utilization control in a Medicaid drug program
title_sort valium project: diagnostic restrictions as a utilization control in a medicaid drug program
topic Special Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191364/
https://www.ncbi.nlm.nih.gov/pubmed/10310598
work_keys_str_mv AT boissereevictorr thevaliumprojectdiagnosticrestrictionsasautilizationcontrolinamedicaiddrugprogram
AT keithjohnc thevaliumprojectdiagnosticrestrictionsasautilizationcontrolinamedicaiddrugprogram
AT littledaniell thevaliumprojectdiagnosticrestrictionsasautilizationcontrolinamedicaiddrugprogram
AT boissereevictorr valiumprojectdiagnosticrestrictionsasautilizationcontrolinamedicaiddrugprogram
AT keithjohnc valiumprojectdiagnosticrestrictionsasautilizationcontrolinamedicaiddrugprogram
AT littledaniell valiumprojectdiagnosticrestrictionsasautilizationcontrolinamedicaiddrugprogram

Ejemplares similares